Condition

High Risk of Recurrence (2)

Anlotinib (1)

Gastrointestinal Stromal Tumors (1)

KIT Gene Mutation (1)

Non-metastatic (1)

Radiotherapy (1)

Resected Gastrointestinal Stromal Tumors (1)

Soft Tissue Sarcoma (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Centre Leon Berard (1)

Ruijin Hospital (1)

Collaborator

Intervention

anlotinib (1)

imatinib maintenance (1)

radiotherapy (1)

surgery (1)

Study Documents

Intervention Type

drug (2)

procedure (1)

radiation (1)

Funder Type

Other (2)

Study Type

Interventional (2)

high risk of recurrence

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Soft Tissue Sarcoma, High Risk of Recurrence, Anlotinib Trial in Shanghai (drug, radiation, procedure)

Recruiting

Soft Tissue Sarcoma
+3 more

Anlotinib
+2 more

Shanghai, Shanghai, China

Ruijin Hospital Shanghai Jiao Tong University School of Medicine

Nov 1, 2022

Gastrointestinal Stromal Tumors, Resected Gastrointestinal Stromal Tumors, Non-metastatic Trial in France (Imatinib maintenance)

Recruiting

Gastrointestinal Stromal Tumors
+4 more

Imatinib maintenance

Marseille, Bouches Du Rhône, France
+16 more

Jul 28, 2021